These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38508108)

  • 1. The intracellular concentrations of fluoroquinolones determined the antibiotic resistance response of Escherichia coli.
    Ma X; Kaw HY; Yu J; Yang Q; Zhu L; Wang W
    J Hazard Mater; 2024 May; 469():134057. PubMed ID: 38508108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antibacterial-like activity on a silica surface: fluoroquinolones and their environmental metabolites.
    Lewis G; Juhasz A; Smith E
    Environ Sci Pollut Res Int; 2011 Aug; 19(7):2795-801. PubMed ID: 22311580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental metabolites of fluoroquinolones: synthesis, fractionation and toxicological assessment of some biologically active metabolites of ciprofloxacin.
    Lewis G; Juhasz A; Smith E
    Environ Sci Pollut Res Int; 2011 Aug; 19(7):2697-707. PubMed ID: 22307896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment.
    Adachi F; Yamamoto A; Takakura K; Kawahara R
    Sci Total Environ; 2013 Feb; 444():508-14. PubMed ID: 23291652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
    Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
    Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of the DNA Gyrases in Fluoroquinolone-Resistant Mutants of Francisella novicida.
    Caspar Y; Siebert C; Sutera V; Villers C; Aubry A; Mayer C; Maurin M; Renesto P
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
    Yamane K; Wachino J; Suzuki S; Kimura K; Shibata N; Kato H; Shibayama K; Konda T; Arakawa Y
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3354-60. PubMed ID: 17548499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant prevention concentrations of fluoroquinolones against Campylobacter jejuni isolated from chicken.
    Wang L; Yuanshu Z; Yuhan Z; Yaojie ; Yingxia L
    Vet Microbiol; 2010 Aug; 144(3-4):409-14. PubMed ID: 20226601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of six fluoroquinolones on the expression of four efflux pumps in the multidrug resistant Escherichia coli isolates.
    Liu H; Liu X; Li Y; Hao C
    World J Microbiol Biotechnol; 2015 Jul; 31(7):1041-8. PubMed ID: 25854862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States.
    Liu X; Boothe DM; Jin Y; Thungrat K
    World J Microbiol Biotechnol; 2013 Feb; 29(2):347-54. PubMed ID: 23136054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital.
    Zeana C; Palmieri FE; Gupta V; Ye G; Lao P; Yu K; Kang KS; Schiller L; Purswani M
    Sci Prog; 2021; 104(2):368504211011876. PubMed ID: 33908291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic alterations involved in fluoroquinolone resistance development in Staphylococcus aureus.
    Huynh TQ; Tran VN; Thai VC; Nguyen HA; Nguyen NTG; Tran MK; Nguyen TPT; Le CA; Ho LTN; Surian NU; Chen S; Nguyen TTH
    PLoS One; 2023; 18(7):e0287973. PubMed ID: 37494330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact.
    Shin J; Kim J; Wie SH; Cho YK; Lim SK; Shin SY; Yeom JS; Lee JS; Kweon KT; Lee H; Cheong HJ; Park SH; Park DW; Ryu SY; Chung MH; Yoo S; Pai H
    Microb Drug Resist; 2012 Apr; 18(2):169-75. PubMed ID: 22400491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of fluoroquinolone antibiotics and identification of metabolites/transformation products by liquid chromatography-tandem mass spectrometry.
    Maia AS; Ribeiro AR; Amorim CL; Barreiro JC; Cass QB; Castro PM; Tiritan ME
    J Chromatogr A; 2014 Mar; 1333():87-98. PubMed ID: 24548434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-
    Johnson JR; Porter S; Thuras P; Castanheira M
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and mechanism of fluoroquinolone resistance in Escherichia coli isolated from swine farms in China.
    Cheng P; Yang Y; Li F; Li X; Liu H; Fazilani SA; Guo W; Xu G; Zhang X
    BMC Vet Res; 2020 Jul; 16(1):258. PubMed ID: 32723358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Fluoroquinolone Resistance through Antibiotic Tolerance in Campylobacter jejuni.
    Park M; Kim J; Feinstein J; Lang KS; Ryu S; Jeon B
    Microbiol Spectr; 2022 Oct; 10(5):e0166722. PubMed ID: 36066254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals.
    Liu X; Boothe DM; Thungrat K; Aly S
    Vet Microbiol; 2012 Dec; 161(1-2):159-68. PubMed ID: 22877517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
    Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ
    BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.
    de Lastours V; Fantin B
    Future Microbiol; 2015; 10(7):1241-55. PubMed ID: 26119580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.